Literature DB >> 31573843

Liver GCN2 controls hepatic FGF21 secretion and modulates whole body postprandial oxidation profile under a low-protein diet.

Tristan Chalvon-Demersay1, Joanna Moro1, Patrick C Even1, Catherine Chaumontet1, Daniel Tomé1, Julien Averous2, Julien Piedcoq1, Claire Gaudichon1, Anne-Catherine Maurin2, Pierre Fafournoux2, Dalila Azzout-Marniche1.   

Abstract

General control nonderepressible 2 (GCN2) is a kinase that detects amino acid deficiency and is involved in the control of protein synthesis and energy metabolism. However, the role of hepatic GCN2 in the metabolic adaptations in response to the modulation of dietary protein has been seldom studied. Wild-type (WT) and liver GCN2-deficient (KO) mice were fed either a normo-protein diet, a low-protein diet, or a high-protein diet for 3 wk. During this period, body weight, food intake, and metabolic parameters were followed. In mice fed normo- and high-protein diets, GCN2 pathway in the liver is not activated in WT mice, leading to a similar metabolic profile with the one of KO mice. On the contrary, a low-protein diet activates GCN2 in WT mice, inducing FGF21 secretion. In turn, FGF21 maintains a high level of lipid oxidation, leading to a different postprandial oxidation profile compared with KO mice. Hepatic GCN2 controls FGF21 secretion under a low-protein diet and modulates a whole body postprandial oxidation profile.

Entities:  

Keywords:  fibroblast growth factor 21; general control non-derepressible 2; liver; protein

Mesh:

Substances:

Year:  2019        PMID: 31573843     DOI: 10.1152/ajpendo.00022.2019

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  4 in total

1.  Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction.

Authors:  Cara L Green; Heidi H Pak; Nicole E Richardson; Victoria Flores; Deyang Yu; Jay L Tomasiewicz; Sabrina N Dumas; Katherine Kredell; Jesse W Fan; Charlie Kirsh; Krittisak Chaiyakul; Michaela E Murphy; Reji Babygirija; Gregory A Barrett-Wilt; Joshua Rabinowitz; Irene M Ong; Cholsoon Jang; Judith Simcox; Dudley W Lamming
Journal:  Cell Metab       Date:  2022-02-01       Impact factor: 27.287

Review 2.  Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine.

Authors:  Han Fang; Kirsten P Stone; Laura A Forney; Desiree Wanders; Thomas W Gettys
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 6.055

Review 3.  FGF21 and the Physiological Regulation of Macronutrient Preference.

Authors:  Cristal M Hill; Emily Qualls-Creekmore; Hans-Rudolf Berthoud; Paul Soto; Sangho Yu; David H McDougal; Heike Münzberg; Christopher D Morrison
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

Review 4.  The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model.

Authors:  Redin A Spann; Christopher D Morrison; Laura J den Hartigh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.